home / stock / hcwb / hcwb news

HCWB News and Press, HCW Biologics Inc. From 10/28/21

Stock Information
Company Name: HCW Biologics Inc.
Stock Symbol: HCWB
Market: NASDAQ
Website: hcwbiologics.com
Menu
HCWB HCWB Quote HCWB Short HCWB News HCWB Articles HCWB Message Board
Get HCWB Alerts

News, Short Squeeze, Breakout and More Instantly...
HCWB - OSTK Stock: 11 Reasons Why Overstock Investors Are Overjoyed Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Overstock (NASDAQ: OSTK ) stock is surging higher on Thursday following the release of the company’s earnings report for the third quarter of 2021. Source: Burdun Iliya / Shutterstock.com Let’s h...
HCWB - HCWB Stock: The Big FDA News That Has HCW Biologics Booming Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips HCW Biologics (NASDAQ: HCWB ) stock is rocketing higher on Thursday thanks to a recent update from the U.S. Food and Drug Administration (FDA). Source: CI Photos / Shutterstock.com The good news for HCWB inves...

HCWB - HCW Biologics, InflaRx leads healthcare gainers; Rafael, DBV Technologies among major losers

Gainers: HCW Biologics HCWB +115%, InflaRx IFRX +40%, Inspira Technologies Oxy (NASDAQ:IINN) +37%, Community Health Systems (NYSE:CYH) +16%, Invacare (NYSE:IVC) +11%. Losers: Rafael RFL -80%, DBV Technologies (NASDAQ:DBVT) -13%, Alny...

HCWB - HIVE, HUT and DWAC among pre market gainers

HCW Biologics (NASDAQ:HCWB) +102% after FDA greenlight for HCW9218 pancreatic cancer study InflaRx (NASDAQ:IFRX) +61% as Raymond James upgrades expecting price to quadruple LendingClub (NYSE:LC) +32% on Q3 earnings. DatChat (NASDAQ:DATS) +15% launches social...
HCWB - HCW Biologics shares jump 10% after FDA greenlight for HCW9218 pancreatic cancer study

HCW Biologics (NASDAQ:HCWB) has been cleared by the U.S. FDA to proceed to evaluate its lead drug candidate, HCW9218, in a first-in-human Phase 1b clinical trial in patients with advanced pancreatic cancer. Shares up more than 10% premarket. HCW9218 is an injectable, fusion pro...

HCWB - HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer

Company cleared to proceed with first-in-human clinical trial to evaluate HCW9218, Company’s lead product candidate, in refractory, advanced/metastatic pancreatic cancer MIRAMAR, Fla., Oct. 28, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (N...

HCWB - HCW Biologics Announces Appointment of Two New Members to Board of Directors

MIRAMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), an innovative, biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grad...
HCWB - New Stocks to Watch - Biotech, Mining, Cannabis

Point Roberts, WA and Delta, BC - October 22, 2021 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Mining and Cannabis. Today's stocks have been added to our lists of free st...

HCWB - Sesen Bio, Radius Health leads healthcare gainers; ATI Physical Therapy, HCW Biologics among major losers

Gainers: Sesen Bio (NASDAQ:SESN) +43%, Radius Health (NASDAQ:RDUS) +29%, Valneva SE (NASDAQ:VALN) +15%, Olema Pharmaceuticals (NASDAQ:OLMA) +15%, First Wave BioPharma (NASDAQ:FWBI) +6%. Losers: ATI Physical Therapy (NYSE:ATIP) -20%, HCW Biologics (...

HCWB - MIME, LBTYA and PTEN among after hour movers

Gainers: Green Plains Partners LP (NASDAQ:GPP) +8%. Akero Therapeutics AKRO +5%. Ramaco Resources (NASDAQ:METC) +4%. Mimecast Limited (NASDAQ:MIME) +3%. Liberty Global plc (NASDAQ:LBTYA) +3%. Losers: WD-40 Company WDFC -10%. Xiaobai Maimai (NASDAQ:HX) -4%. New Fortress Energy (...
Previous 10 Next 10